SEVERE COMBINED IMMUNODEFICIENCY (SCID)
Clinical trials for SEVERE COMBINED IMMUNODEFICIENCY (SCID) explained in plain language.
Never miss a new study
Get alerted when new SEVERE COMBINED IMMUNODEFICIENCY (SCID) trials appear
Sign up with your email to follow new studies for SEVERE COMBINED IMMUNODEFICIENCY (SCID), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double transplant breakthrough offers hope for rare immune disorder patients
Disease control ENROLLING_BY_INVITATIONThis study tests a new approach for people aged 5 to 45 with primary immune deficiencies and end-stage lung disease. Participants receive a double lung transplant followed by a stem cell transplant from the same donor. The goal is to see if this combined procedure is safe and can…
Matched conditions: SEVERE COMBINED IMMUNODEFICIENCY (SCID)
Phase: PHASE1, PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Gene therapy survivors monitored for decades in new study
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 70 people who previously received gene therapy for a rare immune disorder called ADA-SCID. Researchers want to see how well the treatment worked over time and check for any long-term side effects. No new treatment is given—just regular health checkups.
Matched conditions: SEVERE COMBINED IMMUNODEFICIENCY (SCID)
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC